Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Fabio TURCO"'
Autor:
Giuseppe Salfi, Martino Pedrani, Selin Candan, Vasile Urechie, Sara Merler, Lorenzo Ruinelli, Amos Colombo, Luis Castelo-Branco, Irene Testi, Fabio Turco, Luigi Tortola, Ursula Vogl, Luca Gabutti, Silke Gillessen, Ricardo Pereira Mestre
Publikováno v:
European Urology Open Science, Vol 71, Iss , Pp 1-10 (2025)
Background and objective: Hypertension (HTN) has been linked to an elevated risk of prostate cancer (PC) development and poorer prognosis in localized cases, and is a common side effect of hormonal PC treatments. However, its relationship with the pr
Externí odkaz:
https://doaj.org/article/bef17657e48c4a8fb39ac7218bd8d552
Autor:
Irene Testi, Giulia Claire Giudice, Giuseppe Salfi, Martino Pedrani, Sara Merler, Fabio Turco, Luigi Tortola, Ursula Vogl
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 6, Pp 1326-1364 (2024)
Advanced urothelial carcinoma (aUC) has a dismal prognosis, with a 5-year survival rate of approximately 10%. Platinum-based chemotherapy has been the backbone of the first-line treatment of aUC for over 40 years. Only in the last decade, the treatme
Externí odkaz:
https://doaj.org/article/50345d19217b432891d671f63e69aa3f
Autor:
Guillaume Grisay, Fabio Turco, Saskia Litiere, Béatrice Fournier, Anna Patrikidou, Enrique Gallardo, Ray McDermott, Ahu Alanya, Silke Gillessen, Bertrand Tombal
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The landscape of treating metastatic prostate cancer has evolved with the addition of Androgen Receptor pathway inhibitor (ARPI) to Androgen Deprivation Therapy (ADT), significantly improving survival rates. However, prolonged use of these therapies
Externí odkaz:
https://doaj.org/article/81835467e73e4364af4a30938a8d05b9
Autor:
Giovanni Farinea, Mariangela Calabrese, Federica Carfì, Isabella Saporita, Stefano Poletto, Marco Donatello Delcuratolo, Fabio Turco, Marco Audisio, Francesco Rosario Di Stefano, Marcello Tucci, Consuelo Buttigliero
Publikováno v:
Cells, Vol 13, Iss 16, p 1396 (2024)
Neuroendocrine differentiation (NED) represents a possible androgen receptor pathway inhibitors (ARPI) resistance mechanism in metastatic castration resistance prostate cancer (mCRPC). As mCRPC with NED has been excluded from clinical trials evaluati
Externí odkaz:
https://doaj.org/article/decb279708334df5b7371aef726bf931
Publikováno v:
Medical Cannabis and Cannabinoids, Vol 6, Iss 1, Pp 130-137 (2023)
The maintenance of homeostasis in the gastrointestinal (GI) tract is ensured by the presence of the endocannabinoid system (ECS), which regulates important physiological activities, such as motility, permeability, fluid secretion, immunity, and visce
Externí odkaz:
https://doaj.org/article/fed3e7967cd0422f92401ecace1206c5
Autor:
Francesco Fiorica, Consuelo Buttigliero, Daniela Grigolato, Marco Muraro, Fabio Turco, Fernando Munoz, Marcello Tucci
Publikováno v:
Current Oncology, Vol 29, Iss 12, Pp 9511-9524 (2022)
In recent years, significant changes have occurred in metastatic hormone-sensitive prostate cancer (mHSPC) management, where docetaxel and new androgen receptor pathway inhibitors (ARPI) have been shown to improve overall survival (OS) compared to an
Externí odkaz:
https://doaj.org/article/58f3749ac387463c8d73e63d03162dfd
Autor:
Raimondo Di Liello, Massimo Di Maio, Francesco Perrone, Fabio Turco, Alessandro Rossi, Piera Gargiulo, Andrea Caglio, Valentina Tuninetti, Eleonora Ghisoni, Laura Marandino, Federica Trastu, Pasquale Lombardi, Annapaola Mariniello, Maria Lucia Reale, Giacomo Aimar, Marco Audisio, Maristella Bungaro, Teresa Gamba, Chiara Paratore
Publikováno v:
BMJ Oncology, Vol 2, Iss 1 (2023)
Objective To assess time trends in the inclusion of health-related quality of life (QoL) among study endpoints and in the reporting of QoL results in study publications, randomised phase III oncology trials published between 2017 and 2021 were compar
Externí odkaz:
https://doaj.org/article/86e07fef3bd84328be6e641e4d24f7b0
Autor:
Fabio Turco, Marcello Tucci, Marco Donatello Delcuratolo, Rosario Francesco Di Stefano, Chiara Pisano, Alessandro Audisio, Marco Audisio, Antonio Ungaro, Cinzia Ortega, Massimo Di Maio, Giorgio Vittorio Scagliotti, Consuelo Buttigliero
Publikováno v:
Cancer Communications, Vol 42, Iss 8, Pp 683-688 (2022)
Externí odkaz:
https://doaj.org/article/d06654afbb024f619266ea998729db80
Autor:
Irene Persano, Massimiliano Cani, Benedetta Del Rio, Giorgia Ferrari, Edoardo Garbo, Elena Parlagreco, Chiara Pisano, Valeria Cetoretta, Marco Donatello Delcuratolo, Fabio Turco, Alessandro Audisio, Cristina Cecchi, Gianmarco Leone, Valerio Maria Napoli, Valentina Bertaglia, Valentina Bianco, Enrica Capelletto, Carmen D’Amiano, Massimo Di Maio, Martina Gianetta, Silvia Novello, Francesco Passiglia, Giorgio Vittorio Scagliotti, Paolo Bironzo
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 165 (2023)
Safety data regarding BNT162b2 in cancer patients (CPs) are scarce. Herein we report the side effects (SEs), the adverse events (AEs), and the patient-reported outcomes (PROs) following BNT162b2 administration in CPs treated at the San Luigi Gonzaga
Externí odkaz:
https://doaj.org/article/2e63b9cd60f041349dda710a43ca1131
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
Pain and depression are leading causes of disability and of profound social and economic burden. Their impact is aggravated by their chronicity and comorbidity and the insufficient efficacy of current treatments. Morphological and functional metaboli
Externí odkaz:
https://doaj.org/article/ab5c1bed9ff5422886dcb289caeeba9b